510(k) Report

510(k) · Cleared

Cleared

BD MAX Vaginal Panel

K191957510(k) TraditionalCleared Oct 21, 201990-day reviewClass II21 CFR 866.3975

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Geneohm Sciences Canada, Inc. (Bd Diagnostics) · PQA Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System

Cleared on Oct 21, 2019 as substantially equivalent to DEN160001 (Geneohm Sciences Canada, Inc. (Bd Diagnostics), 2016) after a 90-day review. Its family tree reaches back 1 generation to 2016. 7 later devices descend from it.

Decided
Oct 21, 2019
Review
90 days
Class
Class II
Product code
PQA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN160001 (2016). 7 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2022: 2 descendants cleared2021: 1 descendant cleared2024: 1 descendant cleared2026: 1 descendant cleared2023: 2 descendants clearedDEN160001 · BD MAX Vaginal Panel, BD MAX Instrument · Geneohm Sciences Canada, Inc. (Bd Diagnostics) · 2016201620182020202220242026
Descendants, by generation 1 generation forward: 4 descendants2 generations forward: 2 descendants3 generations forward: 1 descendant DEN160001 · BD MAX Vaginal Panel, BD MAX Instrument · Geneohm Sciences Canada, Inc. (Bd Diagnostics) · 20160
  1. Root · 1 generation backDEN160001 BD MAX Vaginal Panel, BD MAX InstrumentGeneohm Sciences Canada, Inc. (Bd Diagnostics) · 2016
  2. This deviceK191957 BD MAX Vaginal PanelGeneohm Sciences Canada, Inc. (Bd Diagnostics) · 2019
  3. Descendant · cites it directly · 2 of its ownK212213 Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid · 2022
  4. Descendant · cites it directly · 2 of its ownK201017 BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitGeneohm Sciences Canada, Inc. (Bd Life Sciences) · 2021
  5. Descendant · 2 generations on · 1 of its ownK223653 BD Vaginal PanelBecton, Dickinson and Company · 2023
  6. Descendant · 2 generations on · 1 of its ownK221160 Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid · 2022
  7. Descendant · cites it directly · 0 of its ownK260021 cobas® BV/CVRoche Molecular Systems, Inc. · 2026

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2021: 12022: 22023: 22024: 12026: 1
2021high 2 (2022) · low 0 (2025)2026

Most influential descendants

Showing 5 of 7 · See all
  • K212213Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid · 2022 · cites it directly2descendants
  • K201017BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitGeneohm Sciences Canada, Inc. (Bd Life Sciences) · 2021 · cites it directly2descendants
  • K223653BD Vaginal PanelBecton, Dickinson and Company · 2023 · 2 generations on1descendant
  • K221160Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid · 2022 · 2 generations on1descendant
  • K260021cobas® BV/CVRoche Molecular Systems, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN160001BD MAX Vaginal Panel, BD MAX InstrumentGeneohm Sciences Canada, Inc. (Bd Diagnostics)2016—
0 (this device)K191957BD MAX Vaginal PanelGeneohm Sciences Canada, Inc. (Bd Diagnostics)2019—
+1K212213Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid2022—
+1K201017BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitGeneohm Sciences Canada, Inc. (Bd Life Sciences)2021—
+2K223653BD Vaginal PanelBecton, Dickinson and Company2023—
+2K221160Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid2022—
+1K260021cobas® BV/CVRoche Molecular Systems, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
202220
202320
202410
202610
FIG. 1 — Lineage of K191957, 2016–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PQA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PQA device

  1. #1 K260021 cobas® BV/CVscore 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN160001BD MAX Vaginal Panel, BD MAX Instrument
Summary page 4
…est System OOI Real Time Nucleic Acid Amplification System NSU Instrumentation for Clinical Multiplex Test Systems Predicate Device BD MAX Vaginal Panel (DEN160001) Performance Standards Class II Special Controls Guideline: Nucleic Acid Amplification Assays for the Detection of Trichomonas v…
Geneohm Sciences Canada, Inc. (Bd Diagnostics)2016—

Also cleared against DEN160001: 4 other devices →

What descends from it? (7)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K212213Xpert Xpress MVP, GeneXpert Dx System, GeneXpert Infinity SystemCepheid20222
K201017BD MAX Vaginal Panel, BD MAX System, BD Molecular Swab Collection KitGeneohm Sciences Canada, Inc. (Bd Life Sciences)20212
K260021cobas® BV/CVRoche Molecular Systems, Inc.20260
K243725BD Vaginal PanelBecton, Dickinson and Company20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K212213 (Cepheid, 2022) has gone furthest, with 2 descendants of its own.
  • 4 other devices also cite its predicate DEN160001.

How does its category compare?

All PQA devices

PQA Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · PQA

2in 2024

2016: 12019: 32021: 12022: 22023: 22024: 22026 (partial year): 2
2007high 3 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PQA

87in 2019

2019: 87 days median
2007high 87 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PQA

2in 2018

2018: 2
2007high 2 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PQA

3in 2025

2020: 22021: 42022: 72023: 32024: 52025: 3
2007high 7 (2022) · low 0 (2007)2025

MAUDE reports naming product code PQA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20161—00
20170—00
20180—20
201938700
20200—02
20211—04
20222—07
20232—03
20242—05
20250—03
20262—0—

What is it indicated for?

The BD MAX Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis.…

Read the full statement (164 words)

The BD MAX Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis. The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:

• Bacterial vaginosis markers (Individual markers not reported)

Lactobacillus spp. (L. crispatus and L. jensenii)

Gardnerella vaginalis

Atopobium vaginae

Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)

Megasphaera-1

• Candida spp. (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)

• Candida glabrata

• Candida krusei

• Trichomonas vaginalis

The BD MAX Vaginal Panel is intended to aid in the diagnosis of vaginal infections in women with a clinical presentation consistent with bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K191957: BD MAX Vaginal Panel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191957

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026